Members

FACCNE member Genoskin welcomes new board member

Genoskin strengthens governance with appointment of Fabrice Bouteille to its Executive Board

Genoskin has announced the appointment of Fabrice Bouteille as an independent member of its executive board, marking an important step in the company’s continued growth following its recent Series A funding.

This strategic addition reflects Genoskin’s commitment to reinforcing its governance structure as it accelerates its international expansion and strengthens its footprint across the pharmaceutical, biotechnology, and medical device sectors. By enhancing Board independence, the company is aligning with global best practices—an essential move to support sustainable growth and long-term value creation.

With more than two decades of international leadership experience, Fabrice Bouteille brings deep expertise across healthcare, drug delivery, and MedTech. His career includes senior roles at leading global organizations such as Pfizer, KKR, and Aptar Pharma, where he served as Vice President of Global Sales for Injectables. He currently leads Valexel, advising healthcare companies on strategy, commercial performance, and global expansion.

His appointment brings valuable independent perspective and industry insight to Genoskin’s leadership at a pivotal moment. As the company continues to scale, this strengthened governance will help support its mission to advance human-relevant innovation in drug and medical device development.